dioscin has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azuma, K; Gao, X; Liu, X; Saido, TC; Saito, T; Wang, KY; Wang, X; Zhang, JH; Zhou, Q | 1 |
| Han, K; Jia, N; Sun, C; Wang, C; Zhang, Z | 1 |
2 other study(ies) available for dioscin and Alzheimer Disease
| Article | Year |
|---|---|
Microglia-Based Sex-Biased Neuropathology in Early-Stage Alzheimer's Disease Model Mice and the Potential Pharmacologic Efficacy of Dioscin.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; beta Catenin; Body Weight; Brain; Cytokines; Diosgenin; Disease Models, Animal; Female; Male; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Models, Biological; NF-kappa B; Sex Characteristics; Signal Transduction; Synapses | 2021 |
Dioscin Protects against Aβ1-42 Oligomers-Induced Neurotoxicity via the Function of SIRT3 and Autophagy.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Autophagy; Beclin-1; Cell Line; Diosgenin; Down-Regulation; Humans; Neurons; Peptide Fragments; Protective Agents; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Sirtuin 3; Up-Regulation | 2020 |